Alexandre T. Hertig

INSERM CIC Paris Est
Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 170 publications

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Journal: Transplantation

Published: June 30, 2026

Real-time, Multidisciplinary Approach of Women With Pregnancy-Associated Thrombotic Microangiopathy.

Real-time, Multidisciplinary Approach of Women With Pregnancy-Associated Thrombotic Microangiopathy.

Journal: Kidney international reports

Published: May 23, 2026

Once upon a time in nephrology - Episode 3: A brief history of preeclampsia

Once upon a time in nephrology - Episode 3: A brief history of preeclampsia

Journal: Nephrologie & therapeutique

Published: March 17, 2026

The Surgical Apgar Score is Associated with Delayed Graft Function after Deceased-Donor Kidney Transplantation: A Retrospective Cohort.

The Surgical Apgar Score is Associated with Delayed Graft Function after Deceased-Donor Kidney Transplantation: A Retrospective Cohort.

Journal: Kidney360

Published: February 03, 2026

Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor access.

Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor access.

Journal: Kidney international

Published: November 13, 2025

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy.

Anti-CD38 Therapy With Daratumumab in High-Risk IgA Nephropathy.

Journal: Kidney international reports

Published: October 16, 2025

Qualified prediction system for allograft failure in real world settings: extended validation study.

Qualified prediction system for allograft failure in real world settings: extended validation study.

Journal: BMJ medicine

Published: September 02, 2025

Ethnicity affects relapse-free survival in immunemediated thrombotic thrombocytopenic purpura.

Ethnicity affects relapse-free survival in immunemediated thrombotic thrombocytopenic purpura.

Journal: Haematologica

Published: August 07, 2025

Successful use of recombinant ADAMTS13 in a pregnant patient with immune-mediated thrombotic thrombocytopenic purpura.

Successful use of recombinant ADAMTS13 in a pregnant patient with immune-mediated thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 22, 2025

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura.

Journal: Blood advances

Published: July 01, 2025

Partial endothelial-to-mesenchymal transition associates with endothelial human leukocyte antigen II expression and precedes the development of de novo donor-specific anti-human leukocyte antigen antibodies in kidney recipients experiencing a delayed graft function.

Partial endothelial-to-mesenchymal transition associates with endothelial human leukocyte antigen II expression and precedes the development of de novo donor-specific anti-human leukocyte antigen antibodies in kidney recipients experiencing a delayed graft function.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 20, 2025

Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal Crisis.

Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal Crisis.

Journal: Kidney international reports

Published: November 25, 2024

Showing 1-12 of 170

Last Updated: 09/26/2026